STELLA PHARMA CORPORATION

Autres langues Stella Pharma Corporation

Actions

4888

JP3399680002

Marché Fermé - Japan Exchange Autres places de cotation 08:00:00 02/05/2024			Varia. 5j.	Varia. 1 janv.
302 ^JPY	+1,34%		+3,42%	+5,96%

13/02	Stella Pharma Corporation présente ses prévisions de résultats pour l'exercice fiscal se terminant en mars 2024	CI
2023	Stella Pharma Corporation présente ses prévisions de résultats pour l'exercice fiscal se terminant en mars 2024	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Stella Pharma Corporation Provides Earnings Guidance for the Fiscal Year Ending March 2024	13/02
Stella Pharma Corporation Provides Earnings Guidance for the Fiscal Year Ending March 2024	08/08/23
Stella Pharma Corporation Provides Earnings Guidance for the Fiscal Year Ending March 2024	09/05/23
Stella Pharma Corporation Provides Earnings Guidance for the Full Year Ending March 31, 2023	10/02/23
Stella Pharma Corporation announced that it has received funding from SMBC Nikko Securities Inc.	30/12/22
Stella Pharma Corporation announced that it expects to receive funding from SMBC Nikko Securities Inc.	14/12/22
Stella Pharma Corporation Provides Earnings Guidance for the Year Ending March 31, 2023	09/11/22
Mizuho Securities Co., Ltd. acquired unknown minority stake in Stella Pharma Corporation from INCJ, Ltd.	01/11/22
Sumitomo Heavy Industries, Ltd. - Notice Regarding Our First Overseas Introduction of BNCT in the Hainan Medical Tourism Pilot Zone, China	24/06/22
Certain Common Stock of Stella Pharma Corporation are subject to a Lock-Up Agreement Ending on 18-OCT-2021.	18/10/21
Certain Common Stock of Stella Pharma Corporation are subject to a Lock-Up Agreement Ending on 20-JUL-2021.	20/07/21
Stella Pharma Corporation has completed an IPO in the amount of ¥3.400044 billion.	21/04/21
Stella Pharma Corporation has filed an IPO in the amount of ¥3.769614 billion.	19/03/21
Stella Pharma Corporation announced that it has received ¥3.6 billion in funding from Sumitomo Heavy Industries, Ltd., Innovation Network Corporation of Japan	25/03/16
Stella Pharma Corporation announced that it expects to receive ¥3.6 billion in funding from Sumitomo Heavy Industries, Ltd., Innovation Network Corporation of Japan	24/03/16

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Les meilleurs outils réservés aux abonnés pour augmenter la performance de vos investissements !

Optimiser mes Profits

fermer